Shree Pacetronix P/B Ratio
Shree Pacetronix (SHREEPAC) P/B ratio is 3.04 (High), book value per share ₹45.00 vs Healthcare average P/B of -0.01 — High - Premium to book value, growth expectations or asset-light model. Explore SHREEPAC investment value to estimate fundamental worth using multiple valuation models.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
SHREEPAC P/B Ratio — Valuation Insights & Book Value Analysis
Shree Pacetronix price-to-book ratio interpretation, valuation status and historical context — current P/B 3.04 (High). Read SHREEPAC ex-dividend dates for the complete payout history and dividend yield track record.
- Stock appears overvalued with PB of 3.04, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 46.2% below historical average
- Trading at premium to sector average PB of -0.01
Shree Pacetronix P/B Ratio Historical Trend
SHREEPAC annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Shree Pacetronix share price chart.
SHREEPAC Historical P/B Ratio — Book Value Per Share & Year-End Price
Shree Pacetronix annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 3.54 | ₹45.0 | ₹159.40 | ₹18 | High |
| 2025 | 5.42 | ₹35.0 | ₹189.80 | ₹14 | High |
| 2024 | 3.85 | ₹32.5 | ₹125.00 | ₹13 | High |
| 2023 | 8.67 | ₹25.0 | ₹216.75 | ₹10 | High |
| 2022 | 6.78 | ₹15.0 | ₹101.75 | ₹6 | High |
SHREEPAC vs Healthcare Peers — P/B Ratio Comparison
Shree Pacetronix P/B 3.04 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |